Visit us at Medica, Dusseldorf, Germany 17-20 November 2025 at Hall 16, Stand D17-5 and ask us about our free AI tools and the document builder.
Pure Global

TRYPSIN (IRT) - NEONATAL SCREENING - ANVISA Registration 10298910032

Access comprehensive regulatory information for TRYPSIN (IRT) - NEONATAL SCREENING in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 10298910032 and manufactured by manufacturer not specified. The registration is held by REVVITY DO BRASIL LTDA with validity until Sep 23, 2026.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 2 companies making the same product including WALLAC OY, MBIOLOG DIAGNOSTICOS LTDA, and 3 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
2 Competitors
3 Recent Registrations
10298910032
2 Related Devices
Registration Details
ANVISA Registration Number: 10298910032
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Free consultation

Related Devices (2)

FAMรLIA DE KITS DELFIA/AUTODELFIA IRT NEONATAL TRIPSINA IMUNOREATIVA
Risk Class III

Registration Details

10298910032

250000272199639

00351210000124

Company Information

Dates and Status

Sep 23, 1996

23/09/2026

09/18/2025 19:00:01

FAMรLIA DE KITS DELFIA/AUTODELFIA IRT NEONATAL TRIPSINA IMUNOREATIVA
Risk Class III

Registration Details

10298910032

250000272199639

00351210000124

Company Information

WALLAC OY
Finland
PT: FINLร‚NDIA

Dates and Status

Sep 23, 1996

23/09/2026

09/18/2025 19:00:01

Companies Making Similar Products
Top companies providing products with the same technical name: "TRYPSIN (IRT) - NEONATAL SCREENING"